Open AccessD ‐serine signalling as a prominent determinant of neuronal‐glial dialogue in the healthy and diseased brain
Author(s) -
Billard J.M.
Publication year - 2008
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/j.1582-4934.2008.00315.x
Subject(s) - glutamatergic , neuroscience , nmda receptor , signalling , glutamate receptor , neurotransmission , biology , synaptic plasticity , serine , neuroplasticity , psychology , receptor , microbiology and biotechnology , biochemistry , phosphorylation
• Introduction • D ‐serine in the brain: regional expression and synaptic turnover • D ‐serine regulation of synaptic transmission and plasticity • D ‐serine signalling in normal aging and Alzheimer's disease • D ‐serine signalling and schizophrenia • ConclusionsAbstract Rather different from their initial image as passive supportive cells of the CNS, the astrocytes are now considered as active partners at synapses, able to release a set of gliotransmitter‐like substances to modulate synaptic communication within neuronal networks. Whereas glutamate and ATP were first regarded as main determinants of gliotransmission, growing evidence indicates now that the amino acid D ‐serine is another important player in the neuronal‐glial dialogue. Through the regulation of glutamatergic neurotransmission through both N ‐methyl‐ D ‐aspartate (NMDA‐R) and non‐NMDA‐R, D ‐serine is helping in modelling the appropriate connections in the developing brain and influencing the functional plasticity within neuronal networks throughout lifespan. The understanding of D ‐serine signalling, which has increased linearly in the last few years, gives new insights into the critical role of impaired neuronal‐glial communication in the diseased brain, and offers new opportunities for developing relevant strategies to treat cognitive deficits associated to brain disorders.